News | November 07, 2023
Gland Pharma posts Q2 FY24 consolidated PAT at Rs. 194.08 Cr
Gland Pharma has reported total income of Rs. 1426.57 crores during the period ended September 30, 2023
Gland Pharma has reported total income of Rs. 1426.57 crores during the period ended September 30, 2023
Sun Pharma Advanced Research Company Limited has reported total income of Rs. 29.67 crores during the period ended September 30, 2023
Orchid Pharma reported total income of Rs. 207.11 crores during the period ended September 30, 2023
Tatva Chintan Pharma Chem has reported total income of Rs. 97.42 crores during the period ended September 30, 2023
Lincoln Pharmaceuticals has reported total income of Rs. 164.68 crores during the period ended September 30, 2023
This project will aim to develop a next-generation A3 adenosine receptor drug agonists
Sun Pharmaceutical Industries has reported total income of Rs. 12486.02 crores during the period ended September 30, 2023
NATCO's Pharmacovigilance Department was inspected from October 30, 2023 to November 1, 2023
Mankind Pharma has reported total income of Rs. 2768.07 crores during the period ended September 30, 2023
Ajanta Pharma has reported total income of Rs. 1049.77 crores during the period ended September 30, 2023
Subscribe To Our Newsletter & Stay Updated
